Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001242282 | SCV001415356 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2022-10-21 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 309 of the AIRE protein (p.Ile309Met). This variant is present in population databases (rs74162062, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with AIRE-related conditions. ClinVar contains an entry for this variant (Variation ID: 967385). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on AIRE protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Al Jalila Children’s Genomics Center, |
RCV001242282 | SCV001984725 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2021-02-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002473239 | SCV002770388 | uncertain significance | not provided | 2023-08-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 36703223, CrammerJ2022[Poster]) |
Natera, |
RCV001242282 | SCV002083882 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2020-01-15 | no assertion criteria provided | clinical testing |